These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 10779435)
1. Killer inhibitory receptor (CD158b) modulates the lytic activity of tumor-specific T lymphocytes infiltrating renal cell carcinomas. Guerra N; Guillard M; Angevin E; Echchakir H; Escudier B; Moretta A; Chouaib S; Caignard A Blood; 2000 May; 95(9):2883-9. PubMed ID: 10779435 [TBL] [Abstract][Full Text] [Related]
2. Tumor cells regulate the lytic activity of tumor-specific cytotoxic t lymphocytes by modulating the inhibitory natural killer receptor function. Gati A; Guerra N; Giron-Michel J; Azzarone B; Angevin E; Moretta A; Chouaib S; Caignard A Cancer Res; 2001 Apr; 61(8):3240-4. PubMed ID: 11309272 [TBL] [Abstract][Full Text] [Related]
3. Functional and molecular characterization of a KIR3DL2/p140 expressing tumor-specific cytotoxic T lymphocyte clone infiltrating a human lung carcinoma. Dorothée G; Echchakir H; Le Maux Chansac B; Vergnon I; El Hage F; Moretta A; Bensussan A; Chouaib S; Mami-Chouaib F Oncogene; 2003 Oct; 22(46):7192-8. PubMed ID: 14562047 [TBL] [Abstract][Full Text] [Related]
4. T cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function. Ferrini S; Cambiaggi A; Meazza R; Sforzini S; Marciano S; Mingari MC; Moretta L Eur J Immunol; 1994 Oct; 24(10):2294-8. PubMed ID: 7925558 [TBL] [Abstract][Full Text] [Related]
5. The natural killer-related receptor for HLA-C expressed on T cells from CD3+ lymphoproliferative disease of granular lymphocytes displays either inhibitory or stimulatory function. Cambiaggi A; Orengo AM; Meazza R; Sforzini S; Tazzari PL; Lauria F; Raspadori D; Zambello R; Semenzato G; Moretta L; Ferrini S Blood; 1996 Mar; 87(6):2369-75. PubMed ID: 8630400 [TBL] [Abstract][Full Text] [Related]
6. T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clone. Sensi M; Salvi S; Castelli C; Maccalli C; Mazzocchi A; Mortarini R; Nicolini G; Herlyn M; Parmiani G; Anichini A J Exp Med; 1993 Oct; 178(4):1231-46. PubMed ID: 8376931 [TBL] [Abstract][Full Text] [Related]
7. Characterization of fresh (uncultured) tumour-infiltrating lymphocytes (TIL) and TIL-derived T cell lines from patients with renal cell carcinoma. Mitropoulos D; Kooi S; Rodriguez-Villanueva J; Platsoucas CD Clin Exp Immunol; 1994 Aug; 97(2):321-7. PubMed ID: 8050183 [TBL] [Abstract][Full Text] [Related]
8. Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer. Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Stathopoulos GP; Papamichail M Cancer; 1994 Aug; 74(4):1275-82. PubMed ID: 7914469 [TBL] [Abstract][Full Text] [Related]
9. Phenotype, cytokine production and cytolytic capacity of fresh (uncultured) tumour-infiltrating T lymphocytes in human renal cell carcinoma. Van den Hove LE; Van Gool SW; Van Poppel H; Baert L; Coorevits L; Van Damme B; Ceuppens JL Clin Exp Immunol; 1997 Sep; 109(3):501-9. PubMed ID: 9328129 [TBL] [Abstract][Full Text] [Related]
10. Characterization of the cytolytic activity of CD4+ and CD8+ tumor-infiltrating lymphocytes in human renal cell carcinoma. Finke JH; Rayman P; Alexander J; Edinger M; Tubbs RR; Connelly R; Pontes E; Bukowski R Cancer Res; 1990 Apr; 50(8):2363-70. PubMed ID: 2107973 [TBL] [Abstract][Full Text] [Related]
11. Selective lysis of autologous tumor cells by recurrent gamma delta tumor-infiltrating lymphocytes from renal carcinoma. Choudhary A; Davodeau F; Moreau A; Peyrat MA; Bonneville M; Jotereau F J Immunol; 1995 Apr; 154(8):3932-40. PubMed ID: 7706731 [TBL] [Abstract][Full Text] [Related]
12. Tumor-specific lysis of human renal cell carcinomas by tumor-infiltrating lymphocytes. I. HLA-A2-restricted recognition of autologous and allogeneic tumor lines. Schendel DJ; Gansbacher B; Oberneder R; Kriegmair M; Hofstetter A; Riethmüller G; Segurado OG J Immunol; 1993 Oct; 151(8):4209-20. PubMed ID: 8409397 [TBL] [Abstract][Full Text] [Related]
13. In situ demonstration of renal-cell-carcinoma-specific T-cell clones. Caignard A; Guillard M; Gaudin C; Escudier B; Triebel F; Dietrich PY Int J Cancer; 1996 May; 66(4):564-70. PubMed ID: 8635875 [TBL] [Abstract][Full Text] [Related]
14. Superior antitumor in vitro responses of allogeneic matched sibling compared with autologous patient CD8+ T cells. Kausche S; Wehler T; Schnürer E; Lennerz V; Brenner W; Melchior S; Gröne M; Nonn M; Strand S; Meyer R; Ranieri E; Huber C; Falk CS; Herr W Cancer Res; 2006 Dec; 66(23):11447-54. PubMed ID: 17145892 [TBL] [Abstract][Full Text] [Related]
15. T cell functions of IL-2-activated tumor-infiltrating lymphocytes from renal cell carcinoma. Morita T; Salmeron MA; Hayakawa K; Swanson DA; von Eschenbach AC; Itoh K Reg Immunol; 1992; 4(4):225-35. PubMed ID: 1476875 [TBL] [Abstract][Full Text] [Related]
16. MHC class-I-restricted auto-tumor-specific CD4+CD8- T-cell clones established from autologous mixed lymphocyte-tumor-cell culture (MLTC). Wang P; Vánky F; Klein E Int J Cancer; 1992 Jul; 51(6):962-7. PubMed ID: 1386348 [TBL] [Abstract][Full Text] [Related]
17. TCR gamma delta cytotoxic T lymphocytes expressing the killer cell-inhibitory receptor p58.2 (CD158b) selectively lyse acute myeloid leukemia cells. Dolstra H; Fredrix H; van der Meer A; de Witte T; Figdor C; van de Wiel-van Kemenade E Bone Marrow Transplant; 2001 May; 27(10):1087-93. PubMed ID: 11438826 [TBL] [Abstract][Full Text] [Related]
18. Enhancement of the lytic activity of cloned human CD8 tumour-infiltrating lymphocytes by bispecific monoclonal antibodies. Gorter A; Krüse KM; Schrier PI; Fleuren GJ; van de Griend RJ Clin Exp Immunol; 1992 Jan; 87(1):111-6. PubMed ID: 1531120 [TBL] [Abstract][Full Text] [Related]
19. T cell receptor gene rearrangements and cytotoxic activities of clones isolated from tumour-infiltrating lymphocytes (TIL) from melanoma patients. Pandolfi F; Boyle LA; Trentin L; Oliva A; Kurnick JT Clin Exp Immunol; 1994 Jan; 95(1):141-7. PubMed ID: 8287599 [TBL] [Abstract][Full Text] [Related]